متابعة
Massimo Volpe
Massimo Volpe
Dipartimento di Medicina clinica e Molecolare, Facoltà di Medicina e Psicologia, Università Sapienza
بريد إلكتروني تم التحقق منه على uniroma1.it
عنوان
عدد مرات الاقتباسات
عدد مرات الاقتباسات
السنة
2013 ESH/ESC Guidelines for the management of arterial hypertension
G Mancia, R Fagard, K Narkiewicz, J Redon, A Zanchetti, M Böhm, ...
Arterial Hypertension 17 (2), 69-168, 2013
26584*2013
2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and …
B Williams, G Mancia, W Spiering, E Agabiti Rosei, M Azizi, M Burnier, ...
European heart journal 39 (33), 3021-3104, 2018
139972018
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) The Fifth Joint Task Force of the European Society of Cardiology and Other …
European journal of preventive cardiology 19 (4), 585-667, 2012
71512012
Telmisartan, ramipril, or both in patients at high risk for vascular events
Ontarget Investigators
New England Journal of Medicine 358 (15), 1547-1559, 2008
48462008
† Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text‡: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology …
L Ryden, E Standl, M Bartnik, GV Berghe, J Betteridge, MJ De Boer, ...
European heart journal supplements 9 (suppl_C), C3-C74, 2007
21722007
Cardiorenal end points in a trial of aliskiren for type 2 diabetes
HH Parving, BM Brenner, JJV McMurray, D De Zeeuw, SM Haffner, ...
New England Journal of Medicine 367 (23), 2204-2213, 2012
16142012
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised …
Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with ...
The Lancet 372 (9644), 1174-1183, 2008
12182008
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era
S De Rosa, C Spaccarotella, C Basso, MP Calabrò, A Curcio, PP Filardi, ...
European heart journal 41 (22), 2083-2088, 2020
10092020
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes
P Tricoci, Z Huang, C Held, DJ Moliterno, PW Armstrong, F Van de Werf, ...
New England Journal of Medicine 366 (1), 20-33, 2012
8942012
High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species
F Cosentino, M Eto, P De Paolis, B van der Loo, M Bachschmid, V Ullrich, ...
Circulation 107 (7), 1017-1023, 2003
5962003
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation
F Mahfoud, TF Lüscher, B Andersson, I Baumgartner, R Cifkova, ...
European Heart Journal 34 (28), 2149-2157, 2013
5632013
Effects of proprotein convertase subtilisin/kexin type 9 antibodies in adults with hypercholesterolemia: a systematic review and meta-analysis
EP Navarese, M Kołodziejczak, V Schulze, PA Gurbel, U Tantry, Y Lin, ...
Annals of internal medicine 163 (1), 40-51, 2015
5452015
Acute anti-ischemic effect of testosterone in men with coronary artery disease
GMC Rosano, F Leonardo, P Pagnotta, F Pelliccia, G Panina, ...
Circulation 99 (13), 1666-1670, 1999
5451999
Valsartan for prevention of recurrent atrial fibrillation
P Delise, F Bertocchi, G Maiocchi, E Geraci, E Correale, F Lombardi, ...
New England Journal of Medicine 360 (16), 1606-1617, 2009
4702009
Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian Society of Hypertension
G Iaccarino, G Grassi, C Borghi, C Ferri, M Salvetti, M Volpe
Hypertension 76 (2), 366-372, 2020
4512020
Mammalian target of rapamycin signaling in cardiac physiology and disease
S Sciarretta, M Volpe, J Sadoshima
Circulation research 114 (3), 549-564, 2014
4262014
Current situation of medication adherence in hypertension
B Vrijens, S Antoniou, M Burnier, A De la Sierra, M Volpe
Frontiers in pharmacology 8, 248996, 2017
3602017
The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
M Volpe, M Carnovali, V Mastromarino
Clinical Science 130 (2), 57-77, 2016
3272016
Insulin-like growth factor-1 as a vascular protective factor
E Conti, C Carrozza, E Capoluongo, M Volpe, F Crea, C Zuppi, ...
Circulation 110 (15), 2260-2265, 2004
3272004
Natriuretic peptides in cardiovascular diseases: current use and perspectives
M Volpe, S Rubattu, J Burnett Jr
European heart journal 35 (7), 419-425, 2014
3122014
يتعذر على النظام إجراء العملية في الوقت الحالي. عاود المحاولة لاحقًا.
مقالات 1–20